Observational / Non-Interventional Studies

This site contains information on observational / non-interventional studies sponsored by Lilly that started on or after September 1, 2007 at a minimum. This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have any questions regarding any information contained in this site, please consult a physician.

The studies posted are those where a Lilly marketed product is evaluated in comparison to alternative treatment(s) or control group(s), using pre-defined hypotheses/endpoints. These include:

• Studies with primary patient-level data collection
  • Prospective effectiveness studies evaluating the extent to which treatment with a Lilly marketed product improves patient outcomes compared to the alternative treatments in actual clinical practice.
  • Prospective pharmacoepidemiologic studies, ie studies which are designed to assess the risk attributed to a drug exposure.
  
  
• Studies utilizing secondary data sources or databases with safety as the primary endpoint
• Retrospective pharmacoepidemiologic studies, ie studies which are designed to assess the risk attributed to a drug exposure.

Initiated Observational / Non-Interventional Studies: Provides a list of initiated and on-going observational / non-interventional studies.

Results Observational / Non-Interventional Studies: Provides a list of initiated and on-going observational / non-interventional studies.